← Evidence map

ArticleCancer chemotherapy and pharmacology2022

Hsp90 inhibition sensitizes DLBCL cells to cisplatin.

Linnéa Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35190872